Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature: Response to Comment

Curr Rheumatol Rep. 2017 Aug;19(8):52. doi: 10.1007/s11926-017-0676-2.
No abstract available

Keywords: Antiphospholipid antibodies; Antiphospholipid syndrome; Direct oral anticoagulants; Rivaroxaban; Thrombosis; Triple positivity.

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants
  • Antiphospholipid Syndrome*
  • Humans
  • Warfarin*


  • Anticoagulants
  • Warfarin